Prospective randomized controlled study of transarterial chemoembolization with doxorubicin versus doxorubicin/lobaplatin/mitomycin combination for unresectable hepatocellular carcinoma

Chinese Journal of Clinical Oncology

Volumn 36, Issue 1, 2009, Pages 9-12

  Shi, Ming ^a   Chen, Ji'an ^a   Lin, Xiaojun ^a   Chen, Minshan ^a   Guo, Rongping ^a   Li, Shengping ^a   Li, Jinqing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Chemoembolization; Chemotherapy protocol; Liver neoplasm; Randomized controlled trials; Survival analysis

Indexed keywords

DOXORUBICIN; GELFOAM; IODINATED POPPYSEED OIL; LOBAPLATIN; MITOMYCIN;

ABDOMINAL INFECTION; ACUTE KIDNEY FAILURE; ARTERY OCCLUSION; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; LIFE TABLE METHOD; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; PORTAL VEIN; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77951598016     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2009.01.003     Document Type: Article

References (14)

1. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseaser. Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42(5): 1208-1236.
2. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology, 2003, 37(2): 429-442. (Pubitemid 36152543)
3. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver[ J]. J Hepatol, 2001, 35(3): 421-430.
4. Stuart K. Chemoembolization in the management of liver tumors [J]. Oncologist, 2003, 8(5): 425-437.
5. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J]. Lancet, 2002, 359(9319): 1734-1739.
6. Lo CM, Ngan H, Tso, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma[J]. Hepatology, 2002, 35(5): 1164-1171.
7. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma[J]. Gastroenterology, 2004, 127(5 Suppl 1): S179-S188.